3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Pain
1
Constipation
1
Interventions
Morphine
7
Fentanyl
5
Radiotherapy
4
Methadone
4
Zoledronic Acid
3
Tapentadol
2
Ropivacaine
2
Pregabalin
2
Prednisone
2
Ketamine
2
Ibandronic Acid
2
Hydromorphone
2
Glutamine
2
Cryotherapy
2
Cryosurgery
2
Bupivacaine
2
Acupuncture Therapy
2
Acetaminophen
2
pegfilgrastim
1
oxycodone naloxone combination
1
naloxegol
1
ixabepilone
1
incobotulinumtoxinA
1
imisopasem manganese
1
cyclobenzaprine
1
cabozantinib
1
acetaminophen, aspirin, caffeine drug combination
1
Zolpidem
1
Surveys and Questionnaires
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pain
×
oxycodone naloxone combination
×
Clear all
NCT01014559
2015-09-28
OXN3505
Mundipharma SAS
Phase 3
Terminated
225 enrolled